Brought to you by 
Cipher pays $Cdn25.5mm for Cardiome's Canadian business portfolio
Mar 2018
Executive Summary
Cipher Pharmaceuticals Inc. is paying $Cdn25.5mm ($19.5mm) to acquire Cardiome Pharma Corp.'s Canadian business portfolio. Cipher will finance the transaction with cash and new debt.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cipher pays $Cdn25.5mm for Cardiome's Canadian business portfolio
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice